Gregory C Hadlock

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. doi request reprint Ex vivo identification of protein-protein interactions involving the dopamine transporter
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Skaggs Hall, 30 South 2000 East, Room 201, Salt Lake City, UT 84121, USA
    J Neurosci Methods 196:303-7. 2011
  2. pmc Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 335:207-12. 2010
  3. pmc Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release
    Pei Wen Chu
    Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, Utah 84112, USA
    J Neurochem 115:325-32. 2010
  4. pmc 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, 30 South 2000 East, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 339:530-6. 2011
  5. pmc Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 329:169-74. 2009

Collaborators

Detail Information

Publications5

  1. doi request reprint Ex vivo identification of protein-protein interactions involving the dopamine transporter
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Skaggs Hall, 30 South 2000 East, Room 201, Salt Lake City, UT 84121, USA
    J Neurosci Methods 196:303-7. 2011
    ..Ex vivo identification of protein-protein interactions will provide new insight into the function and regulation of a variety of synaptic, membrane-associated proteins, including DAT...
  2. pmc Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 335:207-12. 2010
    ....
  3. pmc Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release
    Pei Wen Chu
    Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, Utah 84112, USA
    J Neurochem 115:325-32. 2010
    ..These may contribute to both the decrease in K(+)-stimulated DA release and the persistent dopaminergic deficits caused by METH...
  4. pmc 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, 30 South 2000 East, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 339:530-6. 2011
    ..These data demonstrate that mephedrone has a unique pharmacological profile with both abuse liability and neurotoxic potential...
  5. pmc Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
    Gregory C Hadlock
    Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA
    J Pharmacol Exp Ther 329:169-74. 2009
    ..Furthermore, these data suggest a multifaceted role for D2 receptors in mediating METH-induced alterations of the DAT and its function...